{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T22:19:30Z","timestamp":1771885170743,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.diagmicrobio.2024.116481","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T16:26:09Z","timestamp":1722961569000},"page":"116481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Outcomes of adult patients with multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia treated with monotherapy versus combination therapy in a tertiary hospital"],"prefix":"10.1016","volume":"110","author":[{"given":"Leisa Jeanne Kaye G.","family":"Yee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cybele Lara R.","family":"Abad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian Theodore G.","family":"Cabaluna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodor A.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.diagmicrobio.2024.116481_bib0001","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1164\/rccm.201102-0349OC","article-title":"High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia","volume":"184","author":"Chung","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.diagmicrobio.2024.116481_bib0002","unstructured":"Department of Health - Research Institute for Tropical Medicine. Antimicrobial resistance surveillance program: 2013 annual report. Available at https:\/\/arsp.com.ph. Accessed 07 December 2023."},{"key":"10.1016\/j.diagmicrobio.2024.116481_bib0003","unstructured":"Department of Health - Research Institute for Tropical Medicine. Antimicrobial resistance surveillance program: 2022 annual report. Available at https:\/\/arsp.com.ph. Accessed 12 November 2023."},{"issue":"12","key":"10.1016\/j.diagmicrobio.2024.116481_bib0004","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/cid\/ciab1013","article-title":"Infectious Diseases Society of America Guidance on the Treatment of AmpC \u03b2-lactamase-producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections","volume":"74","author":"Tamma","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2024.116481_bib0005","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad428","article-title":"Infectious diseases society of america antimicrobial-resistant treatment guidance: gram-negative bacterial infections","author":"Tamma","year":"2023","journal-title":"Infectious Dis Soc America"},{"key":"10.1016\/j.diagmicrobio.2024.116481_bib0006","doi-asserted-by":"crossref","first-page":"7660","DOI":"10.12659\/MSM.916356","article-title":"Risk factors for mortality due to ventilator-associated pneumonia in a Chinese hospital: a retrospective study","volume":"25","author":"Feng","year":"2019","journal-title":"Med Sci Monit"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2024.116481_bib0007","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2024.116481_bib0008","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting [published correction appears in Am J Infect Control. 2008 Nov;36(9):655]","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.diagmicrobio.2024.116481_bib0009","series-title":"Cochrane handbook for systematic reviews of interventions version 6.4 (updated august 2023)","article-title":"Chapter 19: Adverse effects","author":"Peryer","year":"2023"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116481_bib0010","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116481_bib0011","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jmii.2023.04.004","article-title":"Mortality and ventilator dependence in critically ill patients with ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii","volume":"56","author":"Kao","year":"2023","journal-title":"J Microbiol Immunol Infect"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2024.116481_bib0012","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jinf.2019.09.012","article-title":"The global prevalence of multidrug-resistance among Acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: A systematic review and meta-analysis","volume":"79","author":"Lim","year":"2019","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116481_bib0013","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/medicina55020049","article-title":"Ventilator-associated pneumonia due to drug-resistant Acinetobacter baumannii: risk factors and mortality relation with resistance profiles, and independent predictors of in-hospital mortality","volume":"55","author":"\u010ciginskien\u0117","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.diagmicrobio.2024.116481_bib0014","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijid.2020.01.022","article-title":"The clinical profile and outcomes of adult patients given intravenous colistin for multidrug-resistant gram negative infections in a Philippine tertiary hospital","volume":"93","author":"Li","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116481_bib0015","doi-asserted-by":"crossref","first-page":"dlaa101","DOI":"10.1093\/jacamr\/dlaa101","article-title":"Evaluation of Vitek\u00ae 2 performance for colistin susceptibility testing for Gram-negative isolates","volume":"2","author":"Khurana","year":"2020","journal-title":"JAC-Antimicrobial Resistance"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2024.116481_bib0016","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3390\/pharmaceutics14061266","article-title":"Effectiveness and nephrotoxicity of loading dose colistin\u2013meropenem versus loading dose colistin\u2013imipenem in the treatment of carbapenem-resistant Acinetobacter baumannii infection","volume":"14","author":"Katip","year":"2022","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2024.116481_bib0017","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jiph.2023.05.024","article-title":"Short versus long course of colistin treatment for carbapenem-resistant A. baumannii in critically ill patients: a propensity score matching study","volume":"16","author":"Katip","year":"2023","journal-title":"J Infect Public Health"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116481_bib0018","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200131","article-title":"Colistin monotherapy versus combination therapy for carbapenem-resistant organisms","volume":"2","author":"Kaye","year":"2023","journal-title":"NEJM Evid"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116481_bib0019","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1473-3099(18)30099-9","article-title":"Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial","volume":"18","author":"Paul","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116481_bib0020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1473-3099(20)30796-9","article-title":"Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial","volume":"21","author":"Bassetti","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2024.116481_bib0021","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/jac\/dkn128","article-title":"Ampicillin\/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp","volume":"61","author":"Oliveira","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2024.116481_bib0022","article-title":"Efficacy and safety of polymyxin E sulfate in the treatment of critically ill patients with carbapenem-resistant organism infections","volume":"9","author":"Lu","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116481_bib0023","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12879-020-05026-2","article-title":"Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis","volume":"20","author":"Lyu","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116481_bib0024","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00582-2017","volume":"50","author":"Torres","year":"2017","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116481_bib0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.diagmicrobio.2024.116481_bib0026","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s40121-021-00541-4","article-title":"Contemporary perspective on the treatment of Acinetobacter baumannii infections: insights from the society of infectious diseases pharmacists","volume":"10","author":"Abdul-Mutakabbir","year":"2021","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.diagmicrobio.2024.116481_bib0027","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jgar.2020.08.021","volume":"24","author":"Liu","year":"2021","journal-title":"J Glob Antimicrob Resist"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889324003079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889324003079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T11:09:40Z","timestamp":1725102580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889324003079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0732889324003079"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116481","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of adult patients with multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia treated with monotherapy versus combination therapy in a tertiary hospital","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116481"}}